Evidence based medicine and justice: a framework for looking at the impact of EBM upon vulnerable or disadvantaged groups
暂无分享,去创建一个
[1] Jonathan A C Sterne,et al. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. , 2001, BMJ.
[2] Richard Horton,et al. Medical journals: evidence of bias against the diseases of poverty , 2003, The Lancet.
[3] Shah Ebrahim,et al. Dietary fat intake and prevention of cardiovascular disease: systematic review , 2001, BMJ : British Medical Journal.
[4] Jeroan J Allison,et al. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. , 2000, The New England journal of medicine.
[5] H. Kohl. Physical activity and cardiovascular disease: evidence for a dose response. , 2001, Medicine and science in sports and exercise.
[6] W. McCaskill-Stevens,et al. Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. , 2000, Annals of epidemiology.
[7] T. Dent,et al. From guidance to practice: Why NICE is not enough , 2002, BMJ : British Medical Journal.
[8] D Elbourne,et al. Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey , 2001, BMJ : British Medical Journal.
[9] D. Horrobin. Are large clinical trials in rapidly lethal diseases usually unethical? , 2003, The Lancet.
[10] M. Christian,et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Bailar,et al. Selection and description of cancer clinical trials participants—Science or happenstance? , 2002, Cancer.
[12] H. Matthews. Racial, Ethnic and Gender Differences in Response to Medicines , 1995, Drug metabolism and drug interactions.
[13] Malcolm A. Smith,et al. Equal Participation of Minority Patients in U.S. National Pediatric Cancer Clinical Trials , 1997, Journal of pediatric hematology/oncology.
[14] D. Banks,et al. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999. , 2001, Journal of the National Medical Association.
[15] W. Rogers. Evidence‐based medicine in practice: limiting or facilitating patient choice? , 2002, Health expectations : an international journal of public participation in health care and health policy.
[16] B Starfield,et al. New paradigms for quality in primary care. , 2001, The British journal of general practice : the journal of the Royal College of General Practitioners.
[17] P. Sidley. Doctor reprimanded for giving antiretroviral drug to baby who was raped , 2002, British medical journal.
[18] W. McCaskill-Stevens,et al. Participation of Minorities in Cancer Research , 2000 .
[19] Peter E. Hilsenrath,et al. The World Health Report 2000 , 2002 .
[20] P. Rochon,et al. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction. , 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[21] Harlan M Krumholz,et al. Representation of the elderly, women, and minorities in heart failure clinical trials. , 2002, Archives of internal medicine.
[22] L. Szczech,et al. Healthcare system interventions for inequality in quality: corrective action through evidence-based medicine. , 2002, Journal of the National Medical Association.
[23] F. McAlister,et al. The Treatment and Prevention of Coronary Heart Disease in Canada: Do Older Patients Receive Efficacious Therapies? , 1999 .
[24] J. M. Macfie. “Single White Male” , 1961 .
[25] J. Johnson,et al. Influence of race or ethnicity on pharmacokinetics of drugs. , 1997, Journal of pharmaceutical sciences.
[26] M. Kagawa-Singer. Improving the validity and generalizability of studies with underserved U.S. populations expanding the research paradigm. , 2000, Annals of epidemiology.
[27] Anne L. Taylor. SERMs, Ethnicity, and Clinical Trials , 2001, Annals of the New York Academy of Sciences.
[28] A. Avenell,et al. Systematic review of randomised controlled trials , 2018 .
[29] K. Burke. NICE may fail to stop “postcode prescribing,” MPs told , 2002, BMJ : British Medical Journal.
[30] European Cooperative Study Group,et al. Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction , 1996, The Lancet.
[31] M Sculpher,et al. Effectiveness, efficiency, and NICE , 2001, BMJ : British Medical Journal.
[32] G. A. Alexander,et al. Racial/ethnic patterns of cancer in the United States, 1988-1992. , 1996 .
[33] L A Moyé,et al. Evaluation of ethnic minorities and gender effects in clinical trials: opportunities lost and rediscovered. , 2001, Journal of the National Medical Association.